Abiraterone Acetate Diastereomer

Status: Under Development

Abiraterone Acetate Diastereomer is an enantiomer of abiraterone acetate prescribed for patients with castration-resistant prostate cancer. Abiraterone -acetate is a prodrug that is converted in vivo to abiraterone having an androgen biosynthesis inhibitory property.

Additional information on Abiraterone Acetate Diastereomer

Catalogue No. VL830014
Molecular Formula C26H33NO2
Molecular Weight 391.56 g/mol
Parent drug Abiraterone
IUPAC Name (3S, 8R, 9S, 10R, 13S, 14S)-10, 13-dimethyl-17-(pyridin-3-yl)-2, 3, 4, 7, 8, 9, 10, 11, 12, 13, 14, 15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
Pharmacopoeial Synonyms N/A
Other Synonyms 17-(Pyridin-3-yl)androsta-5,16-dien-3B-yl acetate
References Mach, Samuel, et al. “Epoxidation Is the Preferred Pathway of First-Stage Metabolism of Abiraterone Acetate in Brown Bullhead (Ameiurus Nebulosus).” Environmental Science and Pollution Research, vol. 26, no. 34, Oct. 2019, pp. 34896–904, https://doi.org/10.1007/s11356-019-06568-y.
Status Under Development

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

Abiraterone Acetate Diastereomer

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.